We identified five co-expressed TF-LDRG pairs that appeared to have promising prognostic predictive value in the testing dataset and, of these, ABHD5-ARID3a was subsequently validated to have good performance in predicting HF in the clinical trial (Figure 11). The gene discussed is ARID3A; the disease is hydrops fetalis.